GLMD
Price
$0.71
Change
-$0.04 (-5.33%)
Updated
Jan 30 closing price
Capitalization
3.93M
59 days until earnings call
Intraday BUY SELL Signals
MAIA
Price
$2.41
Change
+$0.02 (+0.84%)
Updated
Jan 30 closing price
Capitalization
89.25M
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLMD vs MAIA

Header iconGLMD vs MAIA Comparison
Open Charts GLMD vs MAIABanner chart's image
Galmed Pharmaceuticals
Price$0.71
Change-$0.04 (-5.33%)
Volume$69.34K
Capitalization3.93M
MAIA Biotechnology
Price$2.41
Change+$0.02 (+0.84%)
Volume$541.72K
Capitalization89.25M
GLMD vs MAIA Comparison Chart in %
GLMD
Daily Signal:
Gain/Loss:
MAIA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLMD vs. MAIA commentary
Feb 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLMD is a Buy and MAIA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 02, 2026
Stock price -- (GLMD: $0.71 vs. MAIA: $2.41)
Brand notoriety: GLMD and MAIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLMD: 59% vs. MAIA: 49%
Market capitalization -- GLMD: $3.93M vs. MAIA: $89.25M
GLMD [@Biotechnology] is valued at $3.93M. MAIA’s [@Biotechnology] market capitalization is $89.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLMD’s FA Score shows that 1 FA rating(s) are green whileMAIA’s FA Score has 0 green FA rating(s).

  • GLMD’s FA Score: 1 green, 4 red.
  • MAIA’s FA Score: 0 green, 5 red.
According to our system of comparison, both GLMD and MAIA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLMD’s TA Score shows that 5 TA indicator(s) are bullish while MAIA’s TA Score has 5 bullish TA indicator(s).

  • GLMD’s TA Score: 5 bullish, 3 bearish.
  • MAIA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GLMD is a better buy in the short-term than MAIA.

Price Growth

GLMD (@Biotechnology) experienced а -12.88% price change this week, while MAIA (@Biotechnology) price change was -5.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.27%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was +33.81%.

Reported Earning Dates

GLMD is expected to report earnings on Apr 01, 2026.

MAIA is expected to report earnings on Mar 23, 2026.

Industries' Descriptions

@Biotechnology (-4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MAIA($89.2M) has a higher market cap than GLMD($3.93M). MAIA YTD gains are higher at: 57.516 vs. GLMD (-5.396). GLMD has higher annual earnings (EBITDA): -7.11M vs. MAIA (-22.34M). GLMD has more cash in the bank: 19.1M vs. MAIA (10.9M). GLMD (0) and MAIA (0) have equivalent revenues.
GLMDMAIAGLMD / MAIA
Capitalization3.93M89.2M4%
EBITDA-7.11M-22.34M32%
Gain YTD-5.39657.516-9%
P/E Ratio0.02N/A-
Revenue00-
Total Cash19.1M10.9M175%
Total Debt41KN/A-
FUNDAMENTALS RATINGS
GLMD: Fundamental Ratings
GLMD
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
47

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLMDMAIA
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 7 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 6 days ago
89%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
GLMD
Daily Signal:
Gain/Loss:
MAIA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DLPRF0.290.01
+3.15%
DLP RES INC.
CHEAF0.63N/A
N/A
China Eastern Airlines Corp. Ltd.
SOLTF5.44N/A
N/A
Nxera Pharma Co.,Ltd.
EDDYF0.07N/A
N/A
EDISON LITHIUM CORP.
PEGRY15.05-0.20
-1.32%
Pennon Group PLC

GLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLMD has been closely correlated with XBIO. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLMD jumps, then XBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLMD
1D Price
Change %
GLMD100%
-5.33%
XBIO - GLMD
88%
Closely correlated
-4.72%
TPST - GLMD
35%
Loosely correlated
-3.20%
VTVT - GLMD
35%
Loosely correlated
+3.69%
MGX - GLMD
33%
Loosely correlated
-2.53%
ARWR - GLMD
32%
Poorly correlated
+0.30%
More

MAIA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MAIA has been loosely correlated with CRVS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MAIA jumps, then CRVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAIA
1D Price
Change %
MAIA100%
+0.84%
CRVS - MAIA
36%
Loosely correlated
-1.15%
ACRS - MAIA
32%
Poorly correlated
+2.33%
TERN - MAIA
27%
Poorly correlated
+1.17%
GLMD - MAIA
27%
Poorly correlated
-5.33%
DFTX - MAIA
27%
Poorly correlated
-2.09%
More